Atomo Diagnostics Limited (AT1.XA)
Cboe AU · AUD
A$0.017 (+0.00%) as of
Key statistics
- EPS (TTM)
- -0.0100
- 52-week range
- 0.0160 – 0.0470
- Beta
- 1.28
- Revenue (TTM)
- 5.33M
- Profit margin
- -65.87%
- Volume
- 6.33k
About Atomo Diagnostics Limited
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
- Headquarters
- Leichhardt, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.